Johnson & Johnson told to pay £7bn to man who grew breasts after taking autism drug

Dating service
Hand holding pharmaceuticals
Johnson & Johnson plans to appeal the ruling by a Philadelphia court Credit: Chris Ratcliffe/Bloomberg

Drug maker Johnson & Johnson could face a wave of legal action after it was ordered to pay $8bn (£6.6bn) to a man who grew breasts after taking one of its medicines.

The US pharmaceutical giant was ordered to hand the punitive damages award to Nicholas Murray, who is understood to be one of thousands of individuals planning to take action.

Mr Murray, 26, developed breasts after doctors put him on anti-psychotic drug Risperdal as a teenager to treat autism spectrum disorder.

Johnson & Johnson plans to appeal the ruling by a Philadelphia court but faces further legal action by more than 13,000 claimants over its marketing of the drug and failure to warn young men about its health risks.


To continue reading this article

Start a 30-day free trial for unlimited access to Premium articles

  • Unlimited access to Premium articles 
  • Subscriber-only events and experiences
  • Cancel any time

Free for 30 days

then only £2 per week

Save 25% with an annual subscription

Just £75 per year


Register for free and access one Premium article per week

Only subscribers have unlimited access to Premium articles.
Register for free to continue reading this article
Or unlock all Premium articles.
Free for 30 days, then just £1 per week